PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836312
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1836312
Radiosurgery Systems Market size was valued at US$ 658.19 Million in 2024, expanding at a CAGR of 5.30% from 2025 to 2032.
Radiosurgery is a type of external radiation therapy in which a special device positions the patient and precisely delivers a large dose of radiation to the tumor. Radiosurgery, despite its name, is not a surgical procedure. Instead, cancerous tissues are treated using highly focused radiation beams (gamma rays, X-rays, or protons) that do not require a surgical incision or opening. It destroys the DNA of tumor cells, preventing them from reproducing and growing. Stereotactic radiosurgery is a type of radiation therapy that is highly precise. Radiosurgery is used to treat malignant or benign tumors in the brain, spine, and cancer.
Radiosurgery Systems Market- Market Dynamics
Rising cancer prevalence drives growth in the radiosurgery system market.
The rising cancer incidence is expected to drive the growth of the radiosurgery system market in the coming years. Cancer is a type of disease that can develop in almost any organ or tissue in the body when abnormal cells proliferate uncontrollably, cross their normal boundaries, and either spread to other organs or invade neighboring body parts. Radiosurgery and radiotherapy robotics play an important role in cancer treatment because they enable high geometric accuracy, aid in accurate placement and imaging, and provide cutting-edge therapy options for a variety of cancers, including pancreatic cancer.
For instance, according to a February 2024 report published by the World Health Organization, a Switzerland-based intergovernmental organization, the cancer burden is expected to rise to more than 35 million in 2050, a 77% increase from the estimated 20 million in 2022. Lung cancer was the most common cancer in the world, accounting for 2.5 million new cases, or 12.4% of all new cases. Female breast cancer was ranked second (2.3 million cases, 11.6%), followed by colorectal cancer (1.9 million, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). As a result, the rising prevalence of cancer is driving the expansion of the radiosurgery and radiotherapy robotics market.
Radiosurgery Systems Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.30% over the forecast period (2025-2032)
Based on Type segmentation, Linear accelerator systems are predicted to show maximum market share in the year 2025
Based on end-use segmentation, hospitals is the leading end-use in 2025
On the basis of region, North America was the leading revenue generator in 2025
The Global Radiosurgery Systems Market is segmented on the basis of Type, Application, End User, and Region.
The market is divided into four categories based on Type: Linear accelerator systems, Gamma Knife system, and Proton beam therapy. The Linear accelerator systems LINAC segment dominates the market in terms of volume due to its high adoption and installation rates. The high adoption of LINAC is due to its superior efficacy in treating affected areas with a higher dose of radiation while posing a lower risk of damage to healthy cells. Reduced surgical pain is also driving adoption over traditional radiotherapies. Furthermore, several organizations are launching awareness campaigns to inform people about new technologies and their benefits. The factors mentioned above are likely to help the segment grow.
The market is divided into two categories based on end-use: Academic and Research institute, Hospitals. The hospital segment leads the global market. Radiosurgery, a minimally invasive medical procedure, is widely used in hospitals to treat a variety of conditions, particularly brain tumors, arteriovenous malformations (AVMs), and trigeminal neuralgia. In hospitals, radiosurgery is preferred due to its non-invasive nature, often providing an alternative to traditional surgery, particularly for patients who are deemed unsuitable for or unwilling to undergo invasive procedures. Its applications go beyond neurosurgery to include treatments for certain cancers, functional disorders, and vascular abnormalities.
Radiosurgery Systems Market- Geographical Insights
In 2025, North America will have the largest market share, owing to advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative technologies. The United States, in particular, has a large number of healthcare facilities outfitted with advanced radiosurgery systems. The region also benefits from a strong research environment and favorable reimbursement policies, which drive market growth.
Asia-Pacific is expected to experience significant growth in the global radiosurgery systems (neurology devices) market from 2025 to 2032, owing to increased government initiatives to raise awareness, an increase in medical tourism, growing research activities in the region, the availability of massive untapped markets, a large population pool, and a growing demand for quality healthcare in the region.
The radiosurgery robot system market is highly competitive, with several key players vying for market share. Companies are focusing on technological advancements, strategic partnerships, and mergers and acquisitions to improve their market position. The competitive landscape is characterized by ongoing innovation, as companies strive to develop more precise, efficient, and cost-effective radiosurgery systems. The presence of established players, as well as the entry of new companies, are expected to increase competition in the coming years. Leading market players include ACCURAY INCORPORATED, Integra LifeSciences Holding Corp, Siemens (Varian Medical Systems), RefleXion Medical, and Vision RT Ltd. These companies have a strong market presence, providing a diverse range of radiosurgery systems and services. Their broad product portfolios, robust distribution networks, and strong R&D capabilities give them a competitive advantage. These companies are also working to broaden their geographical reach and improve their product offerings through strategic alliances and collaborations.
In March, 2024, Apollo Hospitals has introduced ZAP-X, an innovative gyroscopic radiosurgery platform for the treatment of brain tumors. The platform was inaugurated at the Indraprastha Apollo Hospital in New Delhi. Zap Surgical, a medical device manufacturer headquartered in the United States, will launch the platform in India.